NASDAQ:NEPT - Neptune Wellness Solutions Stock Price, Forecast & News

Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."

Neptune Wellness Solutions Inc (NASDAQ:NEPT) released its quarterly earnings results on Monday, November, 11th. The biotechnology company reported ($0.17) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.04) by $0.13. The biotechnology company had revenue of $4.93 million for the quarter, compared to analyst estimates of $6.42 million. Neptune Wellness Solutions had a negative return on equity of 39.61% and a negative net margin of 187.60%. View Neptune Wellness Solutions' Earnings History.

Neptune Wellness Solutions is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Neptune Wellness Solutions.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Neptune Wellness Solutions.

Media stories about NEPT stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Neptune Wellness Solutions earned a news impact score of 1.7 on InfoTrie's scale. They also assigned headlines about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for Neptune Wellness Solutions.

Some companies that are related to Neptune Wellness Solutions include Portola Pharmaceuticals (PTLA), IGM Biosciences (IGMS), Karyopharm Therapeutics (KPTI), Rocket Pharmaceuticals (RCKT), Dermira (DERM), Phibro Animal Health (PAHC), Opko Health (OPK), Revance Therapeutics (RVNC), RAPT Therapeutics (RAPT), XBiotech (XBIT), Akebia Therapeutics (AKBA), G1 Therapeutics (GTHX), Gossamer Bio (GOSS), Amphastar Pharmaceuticals (AMPH) and Odonate Therapeutics (ODT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Cronos Group (CRON), Tilray (TLRY), Zynerba Pharmaceuticals (ZYNE), Aphria (APHA), Cara Therapeutics (CARA), New Age Beverages (NBEV), OrganiGram (OGI) and Amarin (AMRN).

Shares of NEPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NEPT stock can currently be purchased for approximately $3.02.

Neptune Wellness Solutions has a market capitalization of $284.60 million and generates $18.39 million in revenue each year. The biotechnology company earns $-17,670,000.00 in net income (profit) each year or ($0.14) on an earnings per share basis. Neptune Wellness Solutions employs 58 workers across the globe.View Additional Information About Neptune Wellness Solutions.

The official website for Neptune Wellness Solutions is http://www.neptunecorp.com/.

Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The biotechnology company can be reached via phone at 45-0687-2262 or via email at [email protected]